GALECTIN THERAPEUTICS INC — Director's Dealing 2016

Jan 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2016-01-05

Reporting Person: Greenberg Arthur (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-05	Common Stock	P	1666	$1.72	Acquired	109445	Direct

Footnotes

F1: The shares were purchased in multiple transactions at prices ranging from $1.718 to $1.726. This amount represents the weighted average purchase price of such transactions. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the issuer.